✦ LIBER ✦

Creation of lysine-deficient mutant lymphotoxin-α with receptor selectivity by using phage display

✍ Scribed by Yasuo Yoshioka; Hikaru Watanabe; Tomohiro Morishige; Xinglei Yao; Shinji Ikemizu; Chioko Nagao; Shandar Ahmad; Kenji Mizuguchi; Yasuo Tsutsumi; Yohei Mukai; Naoki Okada; Shinsaku Nakagawa

Book ID: 116399234
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 46 KB
Volume: 48
Category: Article
ISSN: 1043-4666
DOI: 10.1016/j.cyto.2009.07.469

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Creation of lysine-deficient mutant lymp

Creation of lysine-deficient mutant lymphotoxin-α with receptor selectivity by using a phage display system

✍ Yasuo Yoshioka; Hikaru Watanabe; Tomohiro Morishige; Xinglei Yao; Shinji Ikemizu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 772 KB

102 Creation of TNF Receptor1-Selective

102 Creation of TNF Receptor1-Selective Mutant TNF Using Phage Display System

✍ Kyoko Minowa; Yasuo Yoshioka; Yasuhiro Abe; Tetsuya Nomura; Hiromi Nabeshi; Hiro 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Creation of a mutant IFN-α8 with enhance

Creation of a mutant IFN-α8 with enhanced anti-HCV activity using the phage display technique

✍ Tomoyuki Kawara; Yasuhiro Abe; Haruhiko Kamada; Shin-ichi Tsunoda; Masuo Kondoh; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Creation of Interferon-α8 Mutants with A

Creation of Interferon-α8 Mutants with Amino Acid Substitutions Against Interferon-α Receptor-2 Binding Sites Using Phage Display System and Evaluation of Their Biologic Properties

✍ Yamamoto, Kouzo; Taniai, Madoka; Torigoe, Kakuji; Yamamoto, Shigeto; Arai, Norie 📂 Article 📅 2009 🏛 Mary Ann Liebert 🌐 English ⚖ 413 KB

Fine tuning of receptor-selectivity for

Fine tuning of receptor-selectivity for tumor necrosis factor-α using a phage display system with one-step competitive panning

✍ Yasuhiro Abe; Tomoaki Yoshikawa; Masaki Inoue; Tetsuya Nomura; Takeshi Furuya; T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 415 KB

Tumor necrosis factor-a (TNF) is one of the attractive targets for the development of anti-inflammatory and anti-tumor drugs, because it is an important mediator in the pathogenesis of several inflammatory diseases and tumor progression. Thus, there is an increasing need to understand the TNF recept